Stockreport

Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

Mainz Biomed B.V.  (MYNZ) 
PDF BERKELEY, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of c [Read more]